168 related articles for article (PubMed ID: 10492046)
1. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
Loro LL; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
Hum Pathol; 1999 Sep; 30(9):1097-105. PubMed ID: 10492046
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas.
Loro LL; Vintermyr OK; Ibrahim SO; Idris AM; Johannessen AC
Anticancer Res; 2000; 20(5A):2855-60. PubMed ID: 11062693
[TBL] [Abstract][Full Text] [Related]
3. [Bax protein expression in the carcinogenesis of human oral mucosa].
Zeng X; Chen Q; Li B; Tan N
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
Loro LL; Vintermyr OK; Johannessen AC; Liavaag PG; Jonsson R
J Oral Pathol Med; 1999 Feb; 28(2):82-7. PubMed ID: 9950255
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasias.
Loro LL; Johannessen AC; Vintermyr OK
Oral Oncol; 2002 Oct; 38(7):691-8. PubMed ID: 12167422
[TBL] [Abstract][Full Text] [Related]
6. Maintained CD40 and loss of polarised CD40 ligand expression in oral squamous cell carcinoma.
Loro LL; Ohlsson M; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
Anticancer Res; 2001; 21(1A):113-7. PubMed ID: 11299724
[TBL] [Abstract][Full Text] [Related]
7. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.
Jordan RC; Catzavelos GC; Barrett AW; Speight PM
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):394-400. PubMed ID: 9039223
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
Juneja S; Chaitanya NB; Agarwal M
Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
13. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
14. Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
Loro LL; Johannessen AC; Vintermyr OK
J Clin Pathol; 2005 Nov; 58(11):1157-62. PubMed ID: 16254104
[TBL] [Abstract][Full Text] [Related]
15. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
16. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.
Drenning SD; Marcovitch AJ; Johnson DE; Melhem MF; Tweardy DJ; Grandis JR
Clin Cancer Res; 1998 Nov; 4(11):2913-21. PubMed ID: 9829760
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]